JOURNAL of CARDIOLOGY Official Journal of the Japanese College of Cardiology

JOURNAL OF CARDIOLOGY Official Journal of the Japanese College of Cardiology

AUTHOR INFORMATION PACK

TABLE OF CONTENTS XXX

. .

• Description p.1 • Audience p.1 • Impact Factor p.1 • Abstracting and Indexing p.1 • Editorial Board p.2 • Guide for Authors p.4

ISSN: 0914-5087

DESCRIPTION

. The official journal of the Japanese College of Cardiology is an international, English language, peer- reviewed journal publishing the latest findings in cardiovascular medicine. Journal of Cardiology (JC) aims to publish the highest-quality material covering original basic and clinical research on all aspects of cardiovascular disease. Topics covered include ischemic heart disease, cardiomyopathy, valvular heart disease, vascular disease, hypertension, arrhythmia, congenital heart disease, pharmacological and non-pharmacological treatment, new diagnostic techniques, and cardiovascular imaging. JC also publishes a selection of review articles, clinical trials, short communications, and important messages and letters to the editor.

Journal of Cardiology (JC) features an Open Archive. All articles are made free access 12 months after publication.

AUDIENCE

. Specialists in Cardiovascular and Internal Medicine, Cardiovascular Surgery, Pediatric Cardiology, and General and Family Practitioners.

IMPACT FACTOR

. 2020: 3.159 © Clarivate Analytics Journal Citation Reports 2021

ABSTRACTING AND INDEXING

. Science Citation Index Expanded Embase PubMed/Medline Scopus Current Contents - Clinical Medicine

AUTHOR INFORMATION PACK 23 Sep 2021 www.elsevier.com/locate/jjcc 1 EDITORIAL BOARD

. Editor-in-Chief Yasuchika Takeishi, Fukushima Medical University Associate Editors Teiji Akagi, Okayama University Hospital, Okayama Japan Kaoru Dohi, Mie University Yoshihiro Fukumoto, Kurume University Yukihito Higashi, Hiroshima University, Hiroshima Japan Takanori Ikeda, Toho University, Ota-Ku Japan Kei Inai, Tokyo Women's Medical University, Shinjuku, Tokyo Japan Masaharu Ishihara, Hyogo College of Medicine Katsuomi Iwakura, Sakurabashi Watanabe Hospital, Osaka Japan Koichiro Kinugawa, University of Toyama, Toyama Japan Takuya Kishi, International University of Health and Welfare Yoshio Kobayashi, Chiba University Graduate School of Medicine School of Medicine, Chiba Japan Nobuyuki Komiyama, St Luke's International University Masahiko Kurabayashi, Gunma University Graduate School of Medicine School of Medicine Faculty of Medicine, Maebashi Japan Kengo Kusano, National Cerebral and Cardiovascular Center, Suita Japan Yuichiro Maekawa, Hamamatsu University School of Medicine, Hamamatsu Japan Shigeru Makita, Saitama Medical University International Medical Center Goro Matsumiya, Chiba University Graduate School of Medicine School of Medicine, Chiba Japan Naoya Matsumoto, Nihon University Tetsuo Minamino, Kagawa University Faculty of Medicine Graduate School of Medicine Tohru Minamino, Juntendo University School of Medicine Graduate School of Medicine, Tokyo Japan Yoshihiro Morino, Iwate Medical University Hiroshi Morita, Okayama University Graduate School of Medicine Dentistry and Pharmaceutical Sciences, Okayama Japan Yoshihisa Nakagawa, Shiga University of Medical Science Yukiko Nakano, Hiroshima University Mitsuru Ohishi, Kagoshima University, Kagoshima Japan Hiroyuki Okura, Gifu University, Gifu (Gifu, Japan) Koh Ono, Kyoto University, Kyoto, Japan Minoru Ono, The University of Tokyo Kimio Satoh, Tohoku University School of Medicine, Miyagi, Japan Yoshihiro Seo, Nagoya City University Yuji Shiba, Shinshu University Faculty of Engineering Hiroshi Tada, University of Fukui Masafumi Takahashi, Jichi Medical University Center for Molecular Medicine Kei Takase, Tohoku University, Miyagi Japan Kenichi Tsujita, Kumamoto University, Kumamoto Japan Shinichiro Ueda, University of the Ryukyus Masafumi Watanabe, Yamagata University Masafumi Yano, Yamaguchi University, Yamaguchi Japan Akiomi Yoshihisa, Fukushima Medical University Statistical Editor Takeshi Morimoto, Hyogo College of Medicine Executive Editor Takafumi Ishida, Fukushima Medical University International Advisory Board Namsik Chung, Yonsei University Arnold von Eckardstein, University Hospital Zurich Mihai Gheorghiade, Northwestern University Feinberg School of Medicine Robert A. Harrington, STANFORD UNIVERSITY David Holmes Jr., Mayo Foundation for Medical Education and Research Shunichi Homma, Columbia University Sanjiv Kaul, Oregon Health & Science University Henry Krum, Monash University James K. Liao, UNIVERSITY OF CHICAGO Gerald Maurer, Medical University of Vienna Roxana Mehran, MOUNT SINAI HOSPITAL Hiroshi Nakagawa, Shiga University of Medical Science

AUTHOR INFORMATION PACK 23 Sep 2021 www.elsevier.com/locate/jjcc 2 Jae K. Oh, Mayo Foundation for Medical Education and Research Gerhard Schuler, German Cardiology Centre Berlin Takahiro Shiota, Cedars-Sinai Medical Center Daniel I. Simon, Case Western Reserve University School of Medicine Jae-Kwan Song, University of Ulsan College of Medicine Jan A. Staessen, KU Leuven Association Jörg-Ingolf Stein, Medical University of Innsbruck Jonathan Tobis, University of California Los Angeles David Geffen School of Medicine David Waters, University of California San Francisco Founding Editor-in-Chief Tsuguya Sakamoto, The University of Tokyo Former Editors-in-Chief Junichi Yoshikawa (1994–2005), Osaka City University, Osaka Japan Chuwa Tei (2006–2010), Kagoshima University, Kagoshima Japan Atsushi Hirayama (2010–2013), Nihon University, Chiyoda-Ku Japan Hiroshi Ito (2013-2020), Okayama University

AUTHOR INFORMATION PACK 23 Sep 2021 www.elsevier.com/locate/jjcc 3 GUIDE FOR AUTHORS

. INTRODUCTION Journal of Cardiology (JC), one of the official journals of the Japanese College of Cardiology (JCC), is a monthly peer-reviewed international journal in English that is committed to publishing high-quality material of the latest findings in original basic and clinical research on all aspects of cardiovascular medicine.

JC publishes original research articles, review articles, letters to the editor, and other invited content related to cardiovascular health and disease. Topics covered include ischemic heart disease, cardiomyopathy, valvular heart disease, vascular disease, hypertension, arrhythmia, congenital heart disease, pharmacological and nonpharmacological treatments, new diagnostic techniques, and cardiovascular imaging.

Please note, JC no longer accepts case reports; however authors are encouraged to submit them to the sister journal, Journal of Cardiology Cases (JC Cases). For more details, and to submit your case report or case series, go to http://www.journalofcardiologycases.com/. JC will receive materials prepared and submitted according to these instructions. However, we reserve the right to make any changes necessary to make the contribution conform to the editorial standards of the journal, as deemed by the Editorial Board based on the recommendations of the reviewers.

Any contributions accepted for publication will become the copyright of this journal. No responsibility is assumed by the Editorial Board for the opinions or the ethics expressed by the contributors. Correspondence All contributions and all communications relating to the publication should be addressed to:

Editor-in-Chief, Journal of Cardiology c/o Elsevier Japan, 1-9-15 Higashi-Azabu, Minato-ku, Tokyo 106-0044, Japan Fax: +81 3 3589 6364, Tel: +81 3 3589 5037 E-mail: [email protected] ARTICLE TYPES Manuscripts substantially exceeding the word limits specified below will not be sent for review.

Revisions addressing reviewer comments should also not substantially exceed word limits even if reviewers request additional information. Original Articles These may describe original clinical or laboratory research. Word count: no more than 3,500 words (word count does not include title page, abstract, references, tables, and figure legends) Abstract: Structured with the following headings and no more than 300 words: Background, Methods, Results, Conclusions. Figures/Tables: No more than 8 figures and tables. Highlights: Required. Graphical abstract: Required. Reviews Reviews may concern either clinical or laboratory scientific topics. Word count: no more than 4,000 words (word count does not include title page, abstract, references, tables, and figure legends) Abstract: Unstructured and no more than 300 words. Figures/Tables: No more than 8 figures and tables. Highlights: Required Graphical abstract: Required. Letters to the Editor Focus on specific manuscript that has published in JC. Authors of the original article cited in the letter will be invited to reply and publish together, when possible. Word count: no more than 1,000 words, including references. References: no more than 5. Figures/Tables: None Editorial The editors will solicit all editorials. Instructions pertaining to the writing of an editorial will be included with the request from the editorial office. Please do not submit unsolicited editorials. PREPARATION

AUTHOR INFORMATION PACK 23 Sep 2021 www.elsevier.com/locate/jjcc 4 All manuscripts must be submitted electronically to: https://www.editorialmanager.com/jjcc/default.aspx.

Before proceeding to the online submission site, please prepare your manuscript according to the instructions below. Use of word processing software It is important that the file be saved in the native format of the word processor used. The text should be in single-column format. Keep the layout of the text as simple as possible. Most formatting codes will be removed and replaced on processing the article. In particular, do not use the word processor's options to justify text or to hyphenate words. However, do use bold face, italics, subscripts, superscripts etc. When preparing tables, if you are using a table grid, use only one grid for each individual table and not a grid for each row. If no grid is used, use tabs, not spaces, to align columns. The electronic text should be prepared in a way very similar to that of conventional manuscripts (see also the Guide to Publishing with Elsevier). Note that source files of figures, tables and text graphics will be required whether or not you embed your figures in the text. See also the section on Electronic artwork.

To avoid unnecessary errors you are strongly advised to use the 'spell-check' and 'grammar-check' functions of your word processor. SUBMISSION FILES All submissions should be prepared with the following files: Authorship Agreement and Statement of Conflicts of Interest: Every author listed in the manuscript must read and sign the Authorship Agreement and Statement of Conflicts of Interest form. Cover letter: Manuscripts must be submitted with a cover letter stating that: 1) the paper is not under consideration elsewhere; 2) none of the paper's contents have been previously published; 3) all authors have read and approved the manuscript; and 4) the full disclosure of any relationship with industry. A short paragraph telling the editors why the authors think their paper merits publication priority may be included in the cover letter. Potential reviewers may be suggested in the cover letter, as well as reviewers to avoid. Highlights file: Highlights are a short collection of bullet points that convey the core findings of the article. Highlights must be submitted in a separate editable file in the online submission system. Please use 'Highlights' in the file name and include 3 to 5 bullet points (maximum 85 characters, including spaces, per bullet point). You can view example Highlights on our information site. Manuscript file: Manuscripts should be double-spaced and include page numbers. Assemble the manuscript in this order: Title Page, Abstract, Text, Acknowledgments, Funding, Disclosures, References, and Figure legends. Tables (if any) Figures (if any) Graphical abstract (optional): The graphical abstract should summarize the contents of the article in a concise, pictorial form designed to capture the attention of a wide readership. Graphical abstracts should be submitted as a separate file in the online submission system. Image size: Please provide an image with a minimum of 531 × 1328 pixels (h × w) or proportionally more. The image should be readable at a size of 5 × 13 cm using a regular screen resolution of 96 dpi. Preferred file types: TIFF, EPS, PDF or MS Office files. You can view Example Graphical Abstracts on our information site. Authors can make use of Elsevier's Illustration and Enhancement service to ensure the best presentation of their images and in accordance with all technical requirements.Supplementary material (if any)

For all revisions, please note that two additional files are required: Response to Reviewers Tracked changes and clean versions of the revised manuscriptGraphical abstract (required): The graphical abstract should summarize the contents of the article in a concise, pictorial form designed to capture the attention of a wide readership. Graphical abstracts should be submitted as a separate file in the online submission system. Image size: Please provide an image with a minimum of 531 × 1328 pixels (h × w) or proportionally more. The image should be readable at a size of 5 × 13 cm using a regular screen resolution of 96 dpi. Preferred file types: TIFF, EPS, PDF or MS Office files. You can view Example Graphical Abstracts on our information site. Authors can make use of Elsevier's Illustration and Enhancement service to ensure the best presentation of their images and in accordance with all technical requirements.

NOTICE: Provide the Cover letter, Manuscripts and Tables files in Word form MANUSCRIPT CONTENT The order in which these items appear should also be the order in which they appear in your submission.

AUTHOR INFORMATION PACK 23 Sep 2021 www.elsevier.com/locate/jjcc 5 Title page The title page (page 1) should contain these elements:

Article Type Full title of the article (within 25 words) Every authors' full and complete names, academic degrees, and affiliations Corresponding author's Full name, postal address, e-mail, telephone and fax numbers Up to 3-6 keywords or phrases suitable for use in an index. Word count - excluding title page, Abstract, References, Figure legends, and tables. Abstract Provide a structured abstract of no more than 300 words, presenting essential data in 4 paragraphs introduced by separate headings in the following order :

Background - rationale for study Methods - brief presentation of methods Results - brief presentation of significant results Conclusions - succinct statement of study or/and data interpretation A nonstructured abstract is appropriate for review articles. Text's structure Typical main body headings include Introduction, Methods, Results, Discussion, and Conclusion. Create a structured disclosures section at the end of the manuscript with the headings Acknowledgments, Funding, and Disclosures. Introduction Clearly and briefly describe the background and the rational objective of the study, with a review of earlier publications. It is recommended that the previous studies described only be the most relevant. Avoid exhaustive review of the literature. Materials and Methods Clearly describe the subjects and sample size, the experimental procedures and apparatus (manufacturer's name and address) used in the study. In the case of experiments on human or animal subjects, give an account that the methods were regarded as ethically sound. In the event of an original design, the details should be provided. Otherwise, references accompanied by sufficient information for interdisciplinary evaluation will suffice. The type of statistical analysis used must be stated in this section as well as the commercial software. Do not include discussion in this section. Demonstrate precisely all drugs and chemicals used, including generic names, doses, and routes of administration. Results Present the essential results in the text in a clear and concise manner. Use tables and figures to compare and contrast the findings. Do not repeat in the text all the detailed data in the tables or figures. Do not include discussion in this section. In describing the statistical analysis, please define the probability values and prove that the differences reported were found to be statistically significant. Discussion This should explore the significance of the results of the work, not repeat them. A combined Results and Discussion section is often appropriate. Avoid extensive citations and discussion of published literature. Conclusions The main conclusions of the study may be presented separately as a short Conclusions section, or as a subsection of a Discussion or Results and Discussion section. The progress with respect to the available research and the critical elements of the proposed investigation should also be discussed. Acknowledgements Acknowledgements should appear at the end of the article prior to funding, Disclosures and the References.

The Acknowledgement section should include:

The information on previous presentation of the information reported in the article (i.e., the scientific meeting at which the data has already been presented). Anyone who contributed towards the study by making substantial contributions to conception, design, acquisition of data, or analysis and interpretation of data, or who was involved in drafting the manuscript or revising it critically for important intellectual content, but who does not meet the criteria for authorship. Authors should obtain permission to acknowledge from all those mentioned in the Acknowledgements section.

AUTHOR INFORMATION PACK 23 Sep 2021 www.elsevier.com/locate/jjcc 6 Funding All authors are requested to disclose the sources of funding for the study in the 'Funding' section after Acknowledgements.

You are requested to identify who provided financial support for the conduct of the research and/or preparation of the article. The names of funding organizations should be written in full, and Grant numbers should be given in brackets as follows: '[grant number xxxx]'.

The sentence should begin: 'This research was supported by ...'.

If the funding source(s) had no such involvement then should be stated: 'This research received no grant from any funding agency in the public, commercial or not-for-profit sectors.'' Disclosures All authors are requested to disclose any actual or potential conflict of interest including any financial, personal or other relationships with other people or organizations which could inappropriately influence, or be perceived to influence their work. The 'Disclosures' section should appear after Funding.

If no declaration is made then should be stated: 'The Author(s) declare(s) that there is no conflict of interest'.

Examples:

A (author name) serves as a consultant to Z (entity name); B's spouse is chairperson of Y; C received a research grant from X; D received lecture fees from V; E holds a patent on U; F has been reimbursed by T for attending several conferences; G received honoraria for writing promotional material for S; H has no conflict of interest. REFERENCES The authors are responsible for verifying the accuracy of the references. The Vancouver referencing style should be used. List citations numerically in the order they appear in the text. Follow general arrangement, abbreviations, and punctuation as given in "Uniform Requirements for Manuscripts submitted to Biomedical Journals" (J Am Med Assoc 1997;277:927–34) (see also Samples of Formatted References). For periodicals, follow Index Medicus, listing all authors when 6 or fewer; when 7 or more, list only first 6 and add "et al". Personal communications are discouraged. If included, they must be noted parenthetically in the text, dated by month and year, and accompanied by a written acknowledgement. Do not use periods after the authors' initials. Please provide inclusive page numbers, e.g., 51-9. Reference links Increased discoverability of research and high quality peer review are ensured by online links to the sources cited. In order to allow us to create links to abstracting and indexing services, such as Scopus, CrossRef and PubMed, please ensure that data provided in the references are correct. Please note that incorrect surnames, journal/book titles, publication year and pagination may prevent link creation. When copying references, please be careful as they may already contain errors. Use of the DOI is encouraged. Web references As a minimum, the full URL should be given and the date when the reference was last accessed. Any further information, if known (DOI, author names, dates, reference to a source publication, etc.), should also be given. Web references can be listed separately (e.g., after the reference list) under a different heading if desired, or can be included in the reference list. Data references This journal encourages you to cite underlying or relevant datasets in your manuscript by citing them in your text and including a data reference in your Reference List. Data references should include the following elements: author name(s), dataset title, data repository, version (where available), year, and global persistent identifier. Add [dataset] immediately before the reference so we can properly identify it as a data reference. This identifier will not appear in your published article.

AUTHOR INFORMATION PACK 23 Sep 2021 www.elsevier.com/locate/jjcc 7 Reference style Text: Indicate references by number(s) in square brackets in line with the text. The actual authors can be referred to, but the reference number(s) must always be given.

List: Number the references (numbers in square brackets) in the list in the order in which they appear in the text.

Examples:

Reference to a journal publication: [1] Van der Geer J, Hanraads JAJ, Lupton RA. The art of writing a scientific article. J Sci Commun 2010;163:51-9. Reference to a book: [2] Strunk Jr W, White EB. The elements of style. 4th ed. New York: Longman; 2000. Reference to a chapter in an edited book: [3] Mettam GR, Adams LB. How to prepare an electronic version of your article. In: Jones BS, Smith RZ, editors. Introduction to the electronic age, New York: E-Publishing Inc; 2009, p. 281-304. Reference to a website: [4] Cancer Research UK. Cancer statistics reports for the UK, http:// www.cancerresearchuk.org/aboutcancer/statistics/cancerstatsreport/; 2003 [accessed 13.03.03]. Reference to a dataset: [dataset] [5] Oguro M, Imahiro S, Saito S, Nakashizuka T. Mortality data for Japanese oak wilt disease and surrounding forest compositions, Mendeley Data, v1; 2015. http:// dx.doi.org/10.17632/xwj98nb39r.1. FIGURE LEGENDS All figures must have a number, title, and caption. Figures should be cited in numerical order in the text. Supplemental figures should be cited as Online Figure 1, Online Figure 2, etc. Figure titles should be short and followed by a 2 to 3 sentence caption. Your Graphical abstract, if not an existing figure, should be listed first. If the figure has been previously published, cite the figure source in the legend. All abbreviations used in the figure should be identified in alphabetical order at the end of each legend (see also Figures). TABLES Each table should be on a separate page, with the table number and title centered above the table and explanatory notes below the table. Use Arabic numbers. Table numbers must correspond with the order cited in the text. Tables should be self-explanatory, and the data presented in them should not be duplicated in the text or figures.

All tables must have a title. Abbreviations should be listed in a footnote under the table in alphabetical order. Name each column and each row. The headings should be brief, but sufficiently. If previously published tables are used, written permission from the original publisher/author is required. Cite the source of the table in the footnote. FIGURES Figure numbers must correspond with the order in which they are mentioned in the text. Submit each figure as a separate file. Figures should be sized as close as possible to their final print size. Figure titles and captions should appear in the figure legends on a separate page, not attached to the figure. All abbreviations used in the figure should be identified in an alphabetical order at the end of each legend. Use uniform lettering and sizing of your original artwork. Fonts: Arial, Courier, Times New Roman, Symbol, or similar. All symbols used (arrows, circles, etc.) must be explained. Electronic artwork A detailed guide on electronic artwork is available. You are urged to visit this site; some excerpts from the detailed information are given here.

Formats

If your electronic artwork is created in a Microsoft Office application (Word, PowerPoint, Excel) then please supply 'as is' in the native document format. Regardless of the application used other than Microsoft Office, when your electronic artwork is finalized, please 'Save as' or convert the images to one of the following formats (note the resolution requirements for line drawings, halftones, and line/halftone combinations given below): EPS (or PDF): Vector drawings, embed all used fonts. TIFF (or JPEG): Color or grayscale photographs (halftones), keep to a minimum of 300 dpi. TIFF (or JPEG): Bitmapped (pure black & white pixels) line drawings, keep to a minimum of 1000 dpi.

AUTHOR INFORMATION PACK 23 Sep 2021 www.elsevier.com/locate/jjcc 8 TIFF (or JPEG): Combinations bitmapped line/half-tone (color or grayscale), keep to a minimum of 500 dpi.

Please do not:

Supply files that are optimized for screen use (e.g., GIF, BMP, PICT, WPG); these typically have a low number of pixels and limited set of colors; Supply files that are too low in resolution; Submit graphics that are disproportionately large for the content. VIDEOS This journal accepts video material and animation sequences to support and enhance your scientific research. Authors who have video or animation files that they wish to submit with their article are strongly encouraged to include links to these within the body of the article. This can be done in the same way as a figure or table by referring to the video or animation content and noting in the body text where it should be placed. All submitted files should be properly labeled so that they directly relate to the video file's content. In order to ensure that your video or animation material is directly usable, please provide the files in one of our recommended file formats with a preferred maximum size of 150 MB. Video and animation files supplied will be published online in the electronic version of your article in Elsevier Web products, including ScienceDirect. Please supply 'stills' with your files: you can choose any frame from the video or animation or make a separate image. These will be used instead of standard icons and will personalize the link to your video data. For more detailed instructions please visit our video instruction pages. Note: since video and animation cannot be embedded in the print version of the journal, please provide text for both the electronic and the print version for the portions of the article that refer to this content. Supplementary material Supplementary material can support and enhance your scientific research. Supplementary files offer the author additional possibilities to publish supporting applications, high-resolution images, background datasets, sound clips and more. Please note that such items are published online exactly as they are submitted; there is no typesetting involved (supplementary data supplied as an Excel file or as a PowerPoint slide will appear as such online). Please submit the material together with the article and supply a concise and descriptive caption for each file. If you wish to make any changes to supplementary data during any stage of the process, then please make sure to provide an updated file, and do not annotate any corrections on a previous version. Please also make sure to switch off the 'Track Changes' option in any Microsoft Office files as these will appear in the published supplementary file(s). For more detailed instructions please visit our artwork instruction pages. BEFORE YOU BEGIN Ethics in publishing Please see our information on Ethics in publishing. Declaration of interest All authors must disclose any financial and personal relationships with other people or organizations that could inappropriately influence (bias) their work. Examples of potential competing interests include employment, consultancies, stock ownership, honoraria, paid expert testimony, patent applications/registrations, and grants or other funding. Authors must disclose any interests in two places: 1. A summary declaration of interest statement in the title page file (if double anonymized) or the manuscript file (if single anonymized). If there are no interests to declare then please state this: 'Declarations of interest: none'. 2. Detailed disclosures as part of a separate Declaration of Interest form, which forms part of the journal's official records. It is important for potential interests to be declared in both places and that the information matches. More information. Submission declaration Submission of an article implies that the work described has not been published previously (except in the form of an abstract, a published lecture or academic thesis, see 'Multiple, redundant or concurrent publication' for more information), that it is not under consideration for publication elsewhere, that its publication is approved by all authors and tacitly or explicitly by the responsible authorities where the work was carried out, and that, if accepted, it will not be published elsewhere in the same form, in English or in any other language, including electronically without the written consent of the copyright- holder.

AUTHOR INFORMATION PACK 23 Sep 2021 www.elsevier.com/locate/jjcc 9 Contributors All authors should have made substantial contributions to all of the following: (1) the conception and design of the study, or acquisition of data, or analysis and interpretation of data, (2) drafting the article or revising it critically for important intellectual content, (3) final approval of the version to be submitted. Use of inclusive language Inclusive language acknowledges diversity, conveys respect to all people, is sensitive to differences, and promotes equal opportunities. Content should make no assumptions about the beliefs or commitments of any reader; contain nothing which might imply that one individual is superior to another on the grounds of age, gender, race, ethnicity, culture, sexual orientation, disability or health condition; and use inclusive language throughout. Authors should ensure that writing is free from bias, stereotypes, slang, reference to dominant culture and/or cultural assumptions. We advise to seek gender neutrality by using plural nouns ("clinicians, patients/clients") as default/wherever possible to avoid using "he, she," or "he/she." We recommend avoiding the use of descriptors that refer to personal attributes such as age, gender, race, ethnicity, culture, sexual orientation, disability or health condition unless they are relevant and valid. These guidelines are meant as a point of reference to help identify appropriate language but are by no means exhaustive or definitive. Changes to authorship Authors are expected to consider carefully the list and order of authors before submitting their manuscript and provide the definitive list of authors at the time of the original submission. Any addition, deletion or rearrangement of author names in the authorship list should be made only before the manuscript has been accepted and only if approved by the journal Editor. To request such a change, the Editor must receive the following from the corresponding author: (a) the reason for the change in author list and (b) written confirmation (e-mail, letter) from all authors that they agree with the addition, removal or rearrangement. In the case of addition or removal of authors, this includes confirmation from the author being added or removed. Only in exceptional circumstances will the Editor consider the addition, deletion or rearrangement of authors after the manuscript has been accepted. While the Editor considers the request, publication of the manuscript will be suspended. If the manuscript has already been published in an online issue, any requests approved by the Editor will result in a corrigendum. Copyright Upon acceptance of an article, authors will be asked to complete a 'Journal Publishing Agreement' (see more information on this). An e-mail will be sent to the corresponding author confirming receipt of the manuscript together with a 'Journal Publishing Agreement' form or a link to the online version of this agreement.

Subscribers may reproduce tables of contents or prepare lists of articles including abstracts for internal circulation within their institutions. Permission of the Publisher is required for resale or distribution outside the institution and for all other derivative works, including compilations and translations. If excerpts from other copyrighted works are included, the author(s) must obtain written permission from the copyright owners and credit the source(s) in the article. Elsevier has preprinted forms for use by authors in these cases. Role of the funding source You are requested to identify who provided financial support for the conduct of the research and/or preparation of the article and to briefly describe the role of the sponsor(s), if any, in study design; in the collection, analysis and interpretation of data; in the writing of the report; and in the decision to submit the article for publication. If the funding source(s) had no such involvement then this should be stated. Peer review This journal operates a single anonymized review process. All contributions will be initially assessed by the editor for suitability for the journal. Papers deemed suitable are then typically sent to a minimum of two independent expert reviewers to assess the scientific quality of the paper. The Editor is responsible for the final decision regarding acceptance or rejection of articles. The Editor's decision is final. Editors are not involved in decisions about papers which they have written themselves or have been written by family members or colleagues or which relate to products or services in which the editor has an

AUTHOR INFORMATION PACK 23 Sep 2021 www.elsevier.com/locate/jjcc 10 interest. Any such submission is subject to all of the journal's usual procedures, with peer review handled independently of the relevant editor and their research groups. More information on types of peer review. Page charges This journal has no page charges. If you select the open access option, you will be required to pay the standard Elsevier open access fee upon acceptance of your article. Open access Please visit our Open Access page for more information. ADDITIONAL INFORMATION Elsevier Researcher Academy Researcher Academy is a free e-learning platform designed to support early and mid-career researchers throughout their research journey. The "Learn" environment at Researcher Academy offers several interactive modules, webinars, downloadable guides and resources to guide you through the process of writing for research and going through peer review. Feel free to use these free resources to improve your submission and navigate the publication process with ease. Illustration services Elsevier's Author Services offers Illustration Services to authors preparing to submit a manuscript but concerned about the quality of the images accompanying their article. Elsevier's expert illustrators can produce scientific, technical and medical-style images, as well as a full range of charts, tables and graphs. Image 'polishing' is also available, where our illustrators take your image(s) and improve them to a professional standard. Please visit the website to find out more. Language (usage and editing services) Please write your text in good English (American or British usage is accepted, but not a mixture of these). Authors who feel their English language manuscript may require editing to eliminate possible grammatical or spelling errors and to conform to correct scientific English may wish to use the English Language Editing service available from Elsevier's Author Services. Submission Elsevier's online submission system guides you stepwise through the process of entering your article details and uploading your files. The system converts your article files to a single PDF file used in the peer-review process. Editable files (e.g., Word, LaTeX) are required to typeset your article for final publication. All correspondence, including notification of the Editor's decision and requests for revision, is sent by e-mail. Color artwork Please make sure that artwork files are in an acceptable format (TIFF (or JPEG), EPS (or PDF), or MS Office files) and with the correct resolution. If, together with your accepted article, you submit usable color figures then Elsevier will ensure, at no additional charge, that these figures will appear in color online (e.g., ScienceDirect and other sites) regardless of whether or not these illustrations are reproduced in color in the printed version. For color reproduction in print, you will receive information regarding the costs from Elsevier after receipt of your accepted article. Please indicate your preference for color: in print or online only. Further information on the preparation of electronic artwork. Data visualization Include interactive data visualizations in your publication and let your readers interact and engage more closely with your research. Follow the instructions here to find out about available data visualization options and how to include them with your article. Research data This journal encourages and enables you to share data that supports your research publication where appropriate, and enables you to interlink the data with your published articles. Research data refers to the results of observations or experimentation that validate research findings. To facilitate reproducibility and data reuse, this journal also encourages you to share your software, code, models, algorithms, protocols, methods and other useful materials related to the project.

AUTHOR INFORMATION PACK 23 Sep 2021 www.elsevier.com/locate/jjcc 11 Below are a number of ways in which you can associate data with your article or make a statement about the availability of your data when submitting your manuscript. If you are sharing data in one of these ways, you are encouraged to cite the data in your manuscript and reference list. Please refer to the "References" section for more information about data citation. For more information on depositing, sharing and using research data and other relevant research materials, visit the research data page. Data linking If you have made your research data available in a data repository, you can link your article directly to the dataset. Elsevier collaborates with a number of repositories to link articles on ScienceDirect with relevant repositories, giving readers access to underlying data that gives them a better understanding of the research described.

There are different ways to link your datasets to your article. When available, you can directly link your dataset to your article by providing the relevant information in the submission system. For more information, visit the database linking page.

For supported data repositories a repository banner will automatically appear next to your published article on ScienceDirect.

In addition, you can link to relevant data or entities through identifiers within the text of your manuscript, using the following format: Database: xxxx (e.g., TAIR: AT1G01020; CCDC: 734053; PDB: 1XFN). Mendeley Data This journal supports Mendeley Data, enabling you to deposit any research data (including raw and processed data, video, code, software, algorithms, protocols, and methods) associated with your manuscript in a free-to-use, open access repository. During the submission process, after uploading your manuscript, you will have the opportunity to upload your relevant datasets directly to Mendeley Data. The datasets will be listed and directly accessible to readers next to your published article online.

For more information, visit the Mendeley Data for journals page. Data statement To foster transparency, we encourage you to state the availability of your data in your submission. This may be a requirement of your funding body or institution. If your data is unavailable to access or unsuitable to post, you will have the opportunity to indicate why during the submission process, for example by stating that the research data is confidential. The statement will appear with your published article on ScienceDirect. For more information, visit the Data Statement page. AFTER ACCEPTANCE Online proof correction To ensure a fast publication process of the article, we kindly ask authors to provide us with their proof corrections within two days. Corresponding authors will receive an e-mail with a link to our online proofing system, allowing annotation and correction of proofs online. The environment is similar to MS Word: in addition to editing text, you can also comment on figures/tables and answer questions from the Copy Editor. Web-based proofing provides a faster and less error-prone process by allowing you to directly type your corrections, eliminating the potential introduction of errors. If preferred, you can still choose to annotate and upload your edits on the PDF version. All instructions for proofing will be given in the e-mail we send to authors, including alternative methods to the online version and PDF. We will do everything possible to get your article published quickly and accurately. Please use this proof only for checking the typesetting, editing, completeness and correctness of the text, tables and figures. Significant changes to the article as accepted for publication will only be considered at this stage with permission from the Editor. It is important to ensure that all corrections are sent back to us in one communication. Please check carefully before replying, as inclusion of any subsequent corrections cannot be guaranteed. Proofreading is solely your responsibility. Offprints The corresponding author will, at no cost, receive a customized Share Link providing 50 days free access to the final published version of the article on ScienceDirect. The Share Link can be used for sharing the article via any communication channel, including email and social media. For an extra charge, paper offprints can be ordered via the offprint order form which is sent once the article is

AUTHOR INFORMATION PACK 23 Sep 2021 www.elsevier.com/locate/jjcc 12 accepted for publication. Both corresponding and co-authors may order offprints at any time via Elsevier's Author Services. Corresponding authors who have published their article gold open access do not receive a Share Link as their final published version of the article is available open access on ScienceDirect and can be shared through the article DOI link. Author rights As an author you (or your employer or institution) have certain rights to reuse your work. More information. Elsevier supports responsible sharing Find out how you can share your research published in Elsevier journals. AUTHOR INQUIRIES Visit the Elsevier Support Center to find the answers you need. Here you will find everything from Frequently Asked Questions to ways to get in touch. You can also check the status of your submitted article or find out when your accepted article will be published.

AUTHOR INFORMATION PACK 23 Sep 2021 www.elsevier.com/locate/jjcc 13